PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, & PharmaTox Strategic Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316 Oslo, Norway.
Laboratory of Healthcare Research and Pharmacoepidemiology, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, 20126 Milano, Italy.
Int J Environ Res Public Health. 2020 May 28;17(11):3830. doi: 10.3390/ijerph17113830.
Nation-wide information about medication use in pregnancy is lacking for Italy, and no study has so far investigated the prescribed medications which pregnant women deliberately avoid. In this study, we map medication use patterns in pregnancy, as well as the extent and type of prescribed medications which are purposely avoided by pregnant women in Italy. This is a sub-study within the "Multinational Medication Use in Pregnancy Study"-a cross-sectional, web-based study conducted in Italy from 7 November 2011 to 7 January 2012. Using an anonymous electronic questionnaire, we collected data from pregnant women and new mothers on medication use and deliberate avoidance during pregnancy and maternal characteristics. The sample included 926 women residing in Italy. The point prevalence of total medication use was 71.2%. Whereas 61.4% and 12.4% of women reported medication use for the treatment of short and longer-term illnesses, respectively, only 8.8% reported medication use for the treatment of both a short and a longer-term illness in pregnancy. We found no substantial differences in estimates across various geographical areas of Italy. Overall, 26.6% of women reported to have deliberately avoided a prescribed medication in pregnancy-most often nimesulide or ketoprofen, but also antibiotics. We conclude that prenatal exposure to medication is common among women in Italy, but estimates are lower than in other Western countries. Intentional avoidance of important medications by pregnant women raises concerns about the safeguarding of maternal-child health.
意大利缺乏关于孕期用药的全国性信息,也没有研究调查过孕妇有意避免使用的处方药物。在这项研究中,我们绘制了意大利孕妇在孕期的用药模式,以及孕妇有意避免使用的处方药物的范围和类型。这是“多国孕期用药研究”的一项子研究,该研究于 2011 年 11 月 7 日至 2012 年 1 月 7 日在意大利进行,采用了横断面、基于网络的研究方法。我们使用匿名电子问卷收集了意大利孕妇和新妈妈在孕期用药和故意避免用药的情况以及产妇特征的数据。样本包括 926 名居住在意大利的女性。总的用药现患率为 71.2%。61.4%和 12.4%的女性分别报告因短期和长期疾病而用药,只有 8.8%的女性报告因短期和长期疾病同时在孕期用药。我们发现意大利不同地理区域的估计值没有实质性差异。总体而言,26.6%的女性报告在孕期有意避免使用一种处方药物,最常见的是尼美舒利或酮洛芬,但也有抗生素。我们的结论是,意大利孕妇接触药物的情况很常见,但估计值低于其他西方国家。孕妇有意避免使用重要药物,这让人对母婴健康的保护产生了担忧。